About IHBI

Improving health...

Providing innovative solutions...

In our lifetime.

IHBI - The Institute of Health and Biomedical Innovation - is a collaborative institute based at QUT, devoted to improving the health of individuals through research innovation. We combine high quality health research with a commitment to social justice. This means that we do more than develop innovative solutions to health issues. We also apply our solutions to real world experiences to make sure that they are effective. Through our work, we seek to improve the health of individuals and of communities.

IHBI's researchers focus on three broad health areas - prevention; mind and body health; and recovery. Our researchers work to:

• Bridge the gap between science and better health - by developing solutions to real world problems
• Advance health and biomedical innovation by developing new and innovative solutions to health issues
• Make better health a reality in our lifetime - by improving the health of individuals and communities.

IHBI's researchers are clustered into six flexible research domains that emphasise multidisciplinary collaboration.

	Cells & Tissue Domain	Research in burns, fractures, healing, surgery, cancer, disease, and infection.
	Human Health and Wellbeing Domain	Research in dementia, obesity, diabetes, schizophrenia, addiction, melanoma, medical treatment and palliative care.
	Injury Prevention and Rehabilitation Domain	Research in the ageing workforce, work injury, drink driving, sport injury, and road accidents.
	Medical Device Domain	Research in arthritis, osteoarthritis, back pain, spinal injuries, orthopaedics, and trauma injuries.
	Tropical Crops and Biocommodities Domain	Research in hunger, malnutrition, disease, poverty and vitamin deficiencies.
	Vision Improvement Domain	Research in myopia, optical injuries, cataracts, glaucoma, visual rehabilitation, and accident prevention.

IHBI has affiliations with nationally recognised hospitals and health care service providers.

QUT is one of Australia's largest Universities and has a long track record of success in real-word commercial partnerships and sustainable biotech companies.